Nebivolol in patients with coronary slow flow: The right drug for the right case?

Anadolu Kardiyoloji Dergisi

Volumn 9, Issue 4, 2009, Pages 296-297

  Fragasso, Gabriele ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; NEBIVOLOL; NITRIC OXIDE SYNTHASE;

ANGIOCARDIOGRAPHY; AUTONOMIC NERVOUS SYSTEM; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY SLOW FLOW; DRUG MECHANISM; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; PROGNOSIS; QT INTERVAL; SYMPATHETIC TONE; VASCULAR ENDOTHELIUM;

ADRENERGIC BETA-ANTAGONISTS; ANGINA PECTORIS; BENZOPYRANS; BLOOD FLOW VELOCITY; CORONARY CIRCULATION; ETHANOLAMINES; HUMANS; PROGNOSIS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 70349394442     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (30)

1. Montorsi P, Manfredi M, Loaldi A, Fabbiocchi F, Polese A, de Cesare N, et al. Comparison of coronary vasomotor responses to nifedipine in syndrome X and Prinzmetal's angina pectoris. Am J Cardiol 1989; 63: 1198-202.
2. Montorsi P, Cozzi S, Loaldi A, Fabbiocchi F, Polese A, De Cesare N, et al. Acute coronary vasomotor effects of nifedipine and therapeutic correlates in syndrome X. Am J Cardiol 1990; 66: 302-7.
3. Galassi AR, Kaski JC, Crea F, Pupita G, Gavrielides S, Tousoulis D, et al. Heart rate response during exercise testing and ambulatory ECG monitoring in patients with syndrome X. Am Heart J 1991; 122: 458-63.
4. Kaski JC, Crea F, Nihoyannopoulos P, Hackett D, Maseri A. Transient myocardial ischemia during daily life in patients with syndrome X. Am J Cardiol 1986; 58: 1242-7.
5. Greenberg MA, Grose RM, Neuburger N, Silverman R, Strain JE, Cohen MV. Impaired coronary vasodilator responsiveness as a cause of lactate production during pacing-induced ischemia in patients with angina pectoris and normal coronary arteries. J Am Coll Cardiol 1987; 9: 743-5.
6. Leonardo F, Fragasso G, Rosano GM, Pagnotta P, Chierchia SL. Effect of atenolol on QT interval and dispersion in patients with syndrome X. Am J Cardiol 1997; 80: 789-90.
7. Chierchia SL, Fragasso G. Angina with normal coronary arteries: diagnosis, pathophysiology and treatment. Eur Heart J 1996; 1 7 (Suppl G): 14-9.
8. Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, et al. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial. Ann Intern Med. 1997; 126: 955-9.
9. Fragasso G, Cattaneo N, Locatelli M, Caumo A, Pagnotta P, Piatti P, et al. Differential effects of selective beta-adrenergic blockade on insulin sensitivity and release in control subjects and in patients with angina and normal coronary arteries (syndrome X). G Ital Cardiol 1998; 28: 623-9.
10. Poirier L, Cléroux J, Nadeau A, Lacourcière Y. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients. J Hypertens 2001; 19: 1429-35.
11. Olsen MH, Fossum E, Høieggen A, Wachtell K, Hjerkinn E, Nesbitt SD, et al. Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy. J Hypertens 2005; 23: 891-8.
12. Lithell HO. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 1991; 14: 203-9.
13. Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study on women with chest pain and normal angiograms. Circulation 2004; 109: 2518-23.
14. Fragasso G, Chierchia SL, Arioli F, Carandente O, Gerosa S, Carlino M, et al. Coronary slow-flow causing transient myocardial hypoperfusion in patients with cardiac syndrome X: long-term clinical and functional prognosis. Int J Cardiol. 2008 Aug 30.
15. Güneş Y, Tuncer M, Güntekin Ü, Ceylan Y. The effects of nebivolol on p wave duration and dispersion in patients with coronary slow flow. Anadolu Kardiyol Derg 2009; 290-5
16. Yazici M, Demircan S, Aksakal E, Şahin M, Meriç M, Dursun I, et al. Plasma insulin, glucose and lipid levels, and their relations with corrected TIMI frame count in patients with slow coronary flow. Anadolu Kardiyol Derg 2003; 3: 222-6.
17. Yazici M, Aksakal E, Demircan S, Şahin M, Saǧkan O. Is slow coronary flow related with inflammation and procoagulant state? Anadolu Kardiyol Derg 2005; 5: 3-7.
18. Özcan T, Gen R, Akbay E, Horoz M, Akçay B, Gençtoy G, et al. The correlation of thrombolysis in myocardial infarction frame count with insulin resistance in patients with slow coronary flow. Coron Artery Dis 2008; 19: 591-5.
19. Yilmaz H, Demir I, Uyar Z. Clinical and coronary angiographic characteristics of patients with coronary slow flow. Acta Cardiol 2008; 63: 579-84.
20. Nurkalem Z, Alper AT, Orhan AL, Zencirci AE, Sari I, Erer B, et al. Mean platelet volume in patients with slow coronary flow and its relationship with clinical presentation. Turk Kardiyol Dern Ars 2008; 36: 363-7.
21. Acar G, Akçay A, Nacar AB, Tuncer C. Coronary artery fistula associated with slow coronary flow: a rare cause of myocardial ischemia. Anadolu Kardiyol Derg 2008; 8: E32-3.
22. Şen N, Başar N, Maden O, Özcan F, Özlü MF, Güngör O, et al. Increased mean platelet volume in patients with slow coronary flow. Platelets 2009; 20: 23-8.
23. Nurkalem Z, Görgülü S, Uslu N, Orhan AL, Alper AT, Erer B, et al. Longitudinal left ventricular systolic function is impaired in patients with coronary slow flow. Int J Cardiovasc Imaging 2009; 25: 25-32.
24. Nurkalem Z, Tangürek B, Zencirci E, Alper AT, Aksu H, Erer B, et al. Endothelial nitric oxide synthase gene (T-786C) polymorphism in patients with slow coronary flow. Coron Artery Dis 2008; 19: 85-8.
25. Diver DJ, Bier JD, Ferreira PE, Sharaf BL, McCabe C, Thompson B, et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol 1994; 74: 531-7.
26. Kapoor A, Goel PK, Gupta S: Slow coronary flow-a cause for angina with ST segment elevation and normal coronary arteries: a case report. Int J Cardiol 1998; 67: 257-61.
27. Saya S, Hennebry TA, Lozano P, Lazzara R, Schechter E. Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias: a case report and review of literature. Clin Cardiol 2008; 31: 352-5.
28. Cockroft JR, Chowienczyk PJ, Brett AE, Chen CPLH, Dupont AG, Nueten LV, et al. Nebivolol vasodilates human forearm vasculature: evidence for an -arginine/NO-dependent mechanism. J Pharmacol Exp Ther 1995; 274: 1067-71.
29. Piatti PM, Fragasso G, Monti LD, Caumo A, Phan VC, Valsecchi G, et al. Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol 1999; 34: 1452-60.
30. Piatti PM, Fragasso G, Monti LD, Setola E, Lucotti P, Fermo I, et al. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. Circulation 2003; 107: 429-36.